1. Companies

  2. BioMarin Pharmaceutical

BioMarin Pharmaceutical

BioMarin Pharmaceutical

Develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Launch date
Employees
1001-5000 people
Market cap
AUD24.8b
Enterprise valuation
AUD24.6b (Public information from Sep 2024)
San Rafael California (HQ)
http://bmrn.com
http://www.facebook.com/pages/BioLineRx-Ltd/239324682805429https://www.linkedin.com/company/biomarin

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues1.9b1.8b2.1b2.4b2.8b3.1b3.4b
% growth9 %(1 %)14 %15 %16 %11 %10 %
EBITDA(5.8m)48.0m160m310m555m820m1.1b
% EBITDA margin-3 %8 %13 %20 %26 %31 %
Profit859m(64.1m)142m168m402m570m749m
% profit margin46 %(3 %)7 %7 %14 %18 %22 %
EV / revenue8.4x8.6x9.3x7.5x5.9x5.1x4.4x
EV / EBITDA-2674.0x328.5x122.8x58.7x29.8x19.4x14.4x
R&D budget628m629m650m747m---
R&D % of revenue34 %34 %31 %31 %---

Source: Dealroom estimates

    • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

IPO
Total Funding-

Related Content

Recent News about BioMarin Pharmaceutical

Edit

Investments by BioMarin Pharmaceutical

Edit
Zacharon Pharmaceuticals
Zacharon Pharmaceuticals
ACQUISITION by BioMarin Pharmaceutical Jan 2013
LEAD Therapeutics
LEAD Therapeutics
ACQUISITION by BioMarin Pharmaceutical Feb 2010
Prosensa
Prosensa
ACQUISITION by BioMarin Pharmaceutical Nov 2014
Zystor
Zystor
ACQUISITION by BioMarin Pharmaceutical Aug 2010